1.Alleviation of Symptoms by Palliative Care Team in Two Cancer Patients Receiving Chemotherapy
Hiroaki SHIBAHARA ; Natsuko UEMATSU ; Sanae KINOSHITA ; Kaori MANO ; Masahiro AOYAMA ; Satoshi KOBAYASHI ; Kenji TAKAGI ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2011;60(1):31-36
One patient was intervened by our palliative care team (PCT) to relieve neuropathic pain due to postoperative recurrence of rectal cancer. The dosage controlled-release oxycodone was increased, analgesic adjuvant drugs were changed and the administration of betamethasone were started. Furthermore, the number of times the patient took controlled-release oxycodone increased two to three times a day. These changes in medication resulted in relief of symptoms. Cetuximab therapy was given twice during the course. The other patient was intervened by the PCT for right upper limb pain and dyspnea due to postoperative recurrence of breast cancer. Morphine sulfate hydrate and analgesic adjuvant were additionally given. As pain increased three days after the administeration of transdermal fentanyl patches, the patches were changed every other day, instead of every three days. FEC100 therapy was given twice during the course. In the present two cases, the PCT was intervened with great zeal and rapid relief of symptoms resulted. In the meantime chemotherapy proceeded uneventfully. We thought that trust of the chief doctor in the PCT was most important for effective intervention.
2.Success in Pain Management by Switch from Gabapentin to Pregabalin: A Case of Lung Cancer
Hiroaki SHIBAHARA ; Eri IMAI ; Natsuko UEMATSU ; Sanae KINOSHITA ; Kaori MANO ; Ayako YAMAMOTO ; Masahiro AOYAMA ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2011;60(2):104-108
The patient was a woman in her 80s, who was referred to the palliative care team in our hospital for pain due to bone metastases from lung cancer. Although gabapentin and ifenprodil tartrate were administrated in addition to opioids and loxoprofen sodium, and the dose of opioids was increased, pain was not relieved remarkably. A switch from gabapentin to pregabalin brought remarkable pain relief. Before the internal use of pregabalin, the patient was often seen lyiing in bed because of pain. However, by pregabalin, she began to walk, pushing her wheelchair and smile often. Her ability to perform the basic activities of daily living was improved. The switch from gabapentin to pregabalin was one effective option when an analgesic adjuvant for cancer pain was chosen.
3.Successful Pain Control in Cancer Patient on Palliative Therapy by Partial Opioid Rotation
Natsuko UEMATSU ; Hiroaki SHIBAHARA ; Taeko OKAMOTO ; Sanae KINOSHITA ; Kaori MANO ; Masahiro AOYAMA ; Daisaku NISHIMURA ; Akira ITO ; Atsushi YOSHIDA
Journal of the Japanese Association of Rural Medicine 2012;60(6):764-769
Our palliative care team intervened in a patient with sciatica resulting from metastasis to sacral bone after surgery for rectal cancer. Rapid pain control and a change in the route of rescue drug administration from the stoma were needed. Partial opioid rotation was performed. The dose of 25.2 mg in 72 hours in a transdermal fentanyl patch decreased to 16.8 mg in 72 hours, and the dose of 3.6mg in an hour by continuous intravenous injection of morphine was added. The change in the rescue root to intravenous administration by a patient-controlled analgesia pump gave the patient relief from his pain. He was able to attend his daughter's wedding. His family were all pleased with the relief provided. The advantages of this partial opioid rotation are summed up in the following three points: (1) The required time is relatively short; (2) It can be expedient for analgesia due to the addition of different opioids; and (3) The partial opioid rotation produces fewer adverse effects than a full opioid rotation. Adjustment of the amount of drugs for pain relief in cancer patients is important with the situations of the patient and the family taken into consideration fully.
4.Implementation of Liverpool Care Pathway Japanese version to electronic medical chart (FUJITSU HOPE/EGMAIN-FX®)
Hiroaki Shibahara ; Kaoru Watanabe ; Yoko Hasegawa ; Ayako Tsuji ; Kazue Maetsu ; Sanae Kinoshita ; Kazumi Sugiyama ; Koji Kurono ; Tsubasa Hukada ; Daisaku Nishimura
Palliative Care Research 2012;7(1):334-341
Liverpool Care Pathway (LCP) Japanese version was implemented to electronic medical chart (FUJITSU HOPE/EGMAIN-FX®). The processes were needed as follows; preparation of each templates (criteria for use of the LCP/initial assessment, ongoing assessment, and care after death), preparation of pathway/regimen, incorporation of the templates to the pathway and approval in our hospital clinical pathway committee. One problem we encountered was whether to choose an Excel or a template format for each assessment sheet, and the template format was selected as it presented us with a higher degree of convenience, since each field can be expanded into a table on the screen without scrolling and there is little limitation in the letters of the valiance records that can be used in the template format. The complexity of the three records, “the pathway”, “SOAP & focus” for recording opioid use, and “the progress sheet” for recording vital signs, in addition to the inability to expand enough to capture the same field and show changes in the daily pathway over time through night and day work shifts remain a challenge and need to be improved in the future.